chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient reported on 7/15/21 that she started developing chest pain on 7/13/21 and 7/14/21 off and on. She received 1st dose of Pfizer Covid vaccine on 7/9/21. On morning of 7/15/21, the chest pain returned and was a mostly constant, dull chest pain. The patient reported this to the pharmacy around 4 pm on 7/15/21. She said she was not having any shortness of breath or any other symptoms. I advised patient to go to urgent care to be evaluated. Patient agreed to go to urgent care and would inform pharmacy of the outcome.
Was injected into "fatty tissue" on my right arm by certified medical assistant at end of annual physical. Large red swollen and painful reaction on right arm day later, warm, hard, numbness in fingers. Was notified upon further contact that worker had injected in wrong spot - it should be in bicep or leg - no nurses I spoke with have ever heard of vaccine being placed in arm fatty tissue.
Patient was pseudo-tumor cerebri and had a fever (low grade about 101). The discharge summary and neuro consult report received on 1/28/04 states post vaccination pseudotumor cerebri.
pt recvd vax & exp lesions that looked like pimples;pt also exp severe cold,low grade fever,body aches,cough,& congestion;pt's MD reported pt treated w/homeopathic belladona;MD felt cough was not likely d/t varicella vax poss viral
Narrative:  COVID infection following COVID vaccine series 07/08, Pfizer,  dose #1 07/29, Pfizer, dose #2 09/07, Pfizer, dose #3 1/13 COVID swab, result:  detected 12/30 COVID swab, result: detected 12/30 pt cc: cough, fatigue, sore  throat exposure: unknown 1/13 CXR IMPRESSION: No frank pneumonic  infiltrate. 1/20 CXR IMPRESSION: No acute cardiopulmonary disease. 1/20 pt  admit medicine cc: Shortness of breath and back pain dx: COVID19 viral  syndrome, Complicated Bacterial UTI LOS: 2 days 1/22 FIBRINOGEN: 271 1/22  DDIMER: 1.52 1 22 PROCALCITONIN: 0.52
Case number PHEH2014US024308, is an initial spontaneous report received from a nurse on 02 Dec 2014, with a follow up received from nurse on 19 Jan 2015. This report refers to a 39 years old female patient. Her medical history was not reported. Concomitant medications were none. The patient had tolerated the vaccines well in the past. She was vaccinated with FLUVIRIN (batch number: 14511P expiry date: Mar 2015) intramuscularly at a dose of 0.5 ml into the left deltoid on 06 Nov 2014. It was reported that the patient received FLUVIRIN PFS that was stored at 49 degree F for 1 hour 15 minutes. The patient did not experience and any adverse reaction due to the maladministration (incorrect storage of drug). Follow up received from nurse on 19 Jan 2015: updated site of vaccination and reporter comment.
Victim was found unresponsive/cardiac arrest in bed at home in the morning of 8/20/13. Autopsy showed cause of death was myocarditis.
Patient passed out as soon as she got to the waiting area post-vaccination. She was unresponsive for less than 15 seconds before waking up. She was breathing the whole time. We moved her to the ground to avoid any injury if she was to pass out again. We called paramedics who were at the pharmacy within 5 minutes. They checked vital signs and deemed she was ok. Patient walked out of the store on her own with her mother.
- After 2 minutes, immediately light headed  and felt as if I may pass out. Never have had issues with shots before  - heart rate noticeably accelerated during 15 minute waiting period post-vaccination  - a couple of hours later, uncontrollable shaking and teeth chattering with accelerated heart rate. All of a sudden went away - Thursday 4/15, could barely move arm and feeling of accelerated heart rate. A lot of discomfort from these sensations - Friday 4/16, pain in arm alleviated but heart rate still accelerated and pangs of pain in head. At night, numbness/tingling warmth in left hand and random shooting pain in area of left foot, ankle and shins.
Rash (mild) on back and lower abdomen. Scant rash on left mid chest. DTaP/HIB, MMR, and VZV given 3/24/03. No problems, but noticed rash this AM. Has given Tylenol for age for 24 hours. CT Benadryl for 24 hours for age and if no better or condition worsens, follow up with urgent care.
Information has been received on 24-MAY-2018 regarding a case in litigation from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. In 2007, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route administered at a pharmacy as recommended for routine adult health maintenance and for the intended purpose for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster also known as shingles and other complications. During July 2016, the patient was treated at a medical group for a blistering vesicular outbreak, which was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX and/or despite receiving the ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a direct and proximate result of these malfunctions, the pt suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
CHILLS; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills. This report was non-serious. This case, from the same reporter is linked to 20210756561 and 20210756804.
pain in arm; received beyond 6 month dosing window; This case was reported by a other health professional via sales rep and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm and drug dose administration interval too long. On an unknown date, the outcome of the pain in arm and drug dose administration interval too long were unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient received 2nd dose of Shingrix and experienced pain in arm. The patient received 2nd dose beyond 6 month which led to lengthening of vaccination schedule. This was a medication error with harm.
Pt exp unusual pain w/in hrs of vax; w/in 24 hrs pt devel 3 to 4 in welts, redness, & localized lymph node enlargement; 3 days later, signs of redness were still present;
no adverse effects reported; improperly stored dose of vaccine was administered to the patient; This spontaneous report as received from a nurse refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 19-MAR-2019, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # R024144, expiration date: 23-AUG-2020 for prophylaxis (dose and route of administration were not reported) reconstituted in sterile diluent (STERILE DILUENT) (lot # and expiration date were not reported). It was unspecified of sterile diluent underwent any temperature excursions. No adverse effects were reported. Administered dose of vaccine experienced the temperature excursion of 16.6 degrees Fahrenheit for 5 hours. Data logger was involved. There were no previous excursions reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-00950751-1905USA004595: US-00950751-1905USA011854: US-00950751-1905USA011855: US-00950751-1905USA011856: US-00950751-1905USA011858: US-00950751-1905USA011859: US-00950751-1905USA011860: US-00950751-1905USA011861:
The shot was given very high on my shoulder and was extremely painful. My range of motion was limited, but I thought it was normal because all people report pain, but then a few days later my whole shoulder really started to hurt very badly so that it was even waking me up if I rolled over on it at night. It was very, very sore. I thought I might have injured myself somehow, but recently I was told that some people have this strange shoulder reaction that can come later, so I figured I should report it. It's been two months now and the intense pain is gone, but I still do not have full range of motion in my left arm. It still hurts if I try to raise my arm straight up. I don't know if it pierced my bursa or what happened. The pain is deep around the joint of the shoulder.
Swelling and redness at adminstration site that continued for over 24 hours and was hot to the touch and itchy.
Patient felt flushed, hot, faint occurring approximately 30 minutes after receiving vaccine.  "Feels wierd."  Feeling anxious.  At 3:10pm, BP 165/74  HR=78  O2 sat=99%.  At:3:30pm, BP=155/72.  Symptoms improving.  Patient released from clinic at 3:32pm.
Patient reports a dark circle approximately 1 inch in diameter at the site of the injection in 7 days.
Itching but no hives; dizziness; slight headache; This is a spontaneous report from a contactable nurse. A 60-year-old female patient received first dose of BNT162B2 (Batch/lot number: EK5730) intramuscular at Left arm, on 31Dec2020 at single dose for covid-19 immunisation. Medical history included mild Hypertension (HTN), Hypothyroidism, Anxiety, Gastrooesophageal reflux disease (GERD), Hyperlipidemia. Known allergies included Shellfish, SSRI, Demerol, Codeine. The patient did not have covid prior vaccination. Patient had no other vaccine in four weeks. Concomitant medication included lisinopril, levothyroxine, aluminium hydroxide gel, dried, magnesium carbonate (PEPCID), bupropion hydrochloride (WELLBUTRIN), atorvastatin calcium (LIPITOR), acetylsalicylic acid (BABY ASPIRIN), vitamin c [ascorbic acid], calcium, linum usitatissimum seed oil (FLAX SEED OIL), glucosamine, curcuma longa (TURMERIC), ubidecarenone (COQ 10), collagen. The patient experienced itching but no hives, slight headache, dizziness on 31Dec2020 15:30. The patient received Benadryl 25mg for the events. The patient did not have covid tested post vaccination. The outcome of events was recovering.
developed a few hives and a hour later those faded and then two more locations of hives appeared around 3 pm and they are fading again; She got a booster dose today; she got a booster dose today; This is a spontaneous report from a contactable consumer or other non-hcp (patient herself). A 62-year-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number: not reported, Expiry date: Unknown) via an unspecified route of administration on 22Sep2021 as dose 3, single (at the age of 62-year-old) for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient previously received first dose of Pfizer COVID vaccine on 16Mar2021 and the second dose on 06Apr2021 for COVID-19 immunisation. On 22Sep2021, the patient had booster dose today and she got a booster dose today and 35-40 minutes afterwards she developed a few hives and a hour later those faded and then two more locations of hives appeared around 3 pm and they are fading again, on an unspecified date in Sep2021, experienced she would be dead already. Caller stated she feels as though this was related to the vaccine and wants to know if she should not get any booster doses in the future. Caller states that she was assuming that the reaction was not severe because if it was, she would be dead already, so she wants to know if hives has been reported as a reaction. The outcome of the event hives was recovered on Sep2021, she would be dead and patient had booster dose today was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Complete, full body alopecia.  Hair loss began within weeks of receiving the vaccine and continued over then next few months..  Patient has always had a full, thick head of hair.  Patient is now completely bald.  This includes head, eyebrows, face, nose, ears, arms, and legs.
WHEN PATIENT WAS TALKED INTO GETTING INJECTION, PATIENT CAME BACK TO OFFICE WHERE INJECTIONS ARE ADMIN.  HIS FACE HAD APPEARED RED AND WAS TEARY EYED FROM CRYING PREVIOUSLY.  ADMINISTERED H1N1 VACCINE.  SCHOOL NURSE INFORMED ME PATIENT HAD A REACTION AND NEEDED EPINEPHRINE.  PATIENT DENIED ANY SHORTNESS OF BREATH TEMP 104, SWELLING, RASH COMPLAINED OF ITCHING ON RIGHT KNEE.  INFORMED MOTHER TO TAKE CHILD TO HIS MD. INSTUCTED TO GO TO NEAREST ER. CALLED AT 4:30, MOTHER HAD TAKEN CHILD HOME AND GAVE HIM LUKEWARM BATH.  CURRENT ORAL TEMPERATURE OF 99.  SHE WOULD TAKE HIM TO ER IF TEMP INCREASED.
arm was sore and painful/arm painful; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 68-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd October 2020, the patient received the 1st dose of Shingrix. On 2nd October 2020, less than a day after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix in left arm on October and the arm was sore and painful.   The reporter wanted to know if that amount of time would had to be in pain if he received the second injection.   The reporter also wanted to know how much time should wait before receiving a flu injection and if there was some financial assistance available to assist in paying for the Shingrix.    The reporter provided the caller with the Medical Disclaimer and gave the number to our MI department.   The reporter was also given information from content in consumer FAQs and call was transferred to our Patient Assistance Program. The reporter did not consent to follow up.
Child's R arm was swollen, tight and red-also tender to touch. Lasted 48 hrs. Gave Benadryl Motrin and used warm compresses.
Pt vaxed 18JUN92 & on 19JUN92 presented to MD office w/fever, rash, joints were hot, red & large areas of urticaria were noted on trunk/arms; MD consulted & DPH given;
Monday was day of Vaccine.  Right arm (injection site) was very sore on Tuesday..  Woke up at 4:00 am on Wednesday.  Bad headache, nausea, muscle aches and diarrhea all day long.  Took Tylenol and Imitrex for headache.  Didn't help.  Felt a little better in the afternoon of Wednesday, but it came back at night.  Sick with same symptoms (minus diarrhea) all day Thursday.  Headaches were the worst.  By the 4th morning I felt better.
Nausea; Chills; sweats; vomit; This is a spontaneous report from a non-contactable consumer (patient). A 64-year-old female patient received the first dose of BNT162B2 (Lot number and expiry date unknown), via an unspecified route of administration on 02Jan2021 14:15 at SINGLE DOSE in the left arm for COVID-19 immunization. Medical history included depression from an unknown date. Concomitant medication included marijuana, depression meds and sleep meds. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Jan2021 04:00, the patient experienced nausea, chills, sweats and vomit. The patient did not receive any treatment for the events. The outcome of the events was not recovered.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Vaccine recipient received injection low in the arm (8 finger breadths below the AC). She was concerned this was not in the deltoid muscle itself.  Upon review, the vaccine was not injected in the appropriate location for a deltoid IM injection.
Patient developed vomiting shortly after receiving injection on 9/27/19, 2 days post vaccine developed muscle aches which continued to worsen. 4 days after vaccine, muscle pains continued along with red blotchy areas to back and face.
Throat tightness, flushing of face and chest, itchy throat, tearing, red eyes.
Client and his mother reported the client developed dizziness, weakness, "like he had no strength," about 5 hours after the vaccine that lasted 15-20 minutes. Client and his mother denied any other symptoms. The client's mother gave him water and Paracetamol. The client had only eaten breakfast on the day he received the vaccine, and he received the vaccine at 5PM.
pt recvd vax & took a 2-2 1/2 hr nap, woke up w/persistent crying x 4 hrs; called MD; put ice packs on legs & double APAP;
After receiving COVID vaccination started getting various fluctuations  of  very loud sounds in my head ( air wind hissing static) . Over (8) months still having  continuously sounds .
From telephone contact received on 10/29/02, it was reported that a 50 year old male patient vaccinated with Fluzone (lot # U0933AA) on 10/22/02. On 10/25/02, the patient reported having arthritis like symptoms with achiness and a sore throat. These symptoms were resolved within 24 hours.
Erythema, hyperemia, swelling at the injection site of DTaP associated with fever of 103 deg. F. in 2nd day of reaction.
CONFIRMED COVID-19 INFECTION; SICK; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown expiry: unknown) dose was not reported, administered on 17-MAR-2021 for prophylactic vaccination on left arm. The batch number was not reported and has been requested. No concomitant medications were reported.  On 18-MAR-2021, the subject experienced sick. On 24-MAR-2021, Laboratory data included: SARS-CoV-2 rapid POC test (NR: not provided) Positive. On an unspecified date, the subject experienced confirmed covid-19 infection. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sick, and the outcome of confirmed covid-19 infection was not reported. This report was non-serious.
I immunized patient in right arm and she said ouch when I administered at 805pm 2-28-2020. at 343pm on 2-29-2020 patient called and said she had pain from her shoulder down to her fingers, she said she couldn't sleep all nite and felt so awful has been in bed all day, she said she has pain all down her left arm as well(non immunize arm) but not as bad, she said her shoulder blades hurt also. she has a lot of nausea. still doesn't feel well.
had extreme general body aches/pain, headache, blotchy skin, chills, fever
I had what I thought was "normal" pain at the injection site (left shoulder) initially however the pain spread from the injection site downward to my mid triceps by Saturday to Sunday afternoon. By Sunday night my shoulder mobility began to diminish (lifting the arm enough to comfortably shower was challenging). By Monday my shoulder and elbow radiated with pain originating at the injection site. By Monday afternoon I had lost virtually all mobility and strength in shoulder such that I could not raise my arm high enough to wash my left arm/hand enough to wash my hands in a kitchen sink/bathroom (which has NEVER been an issue). Since Monday, any activity that innervates the left shoulder to generate movement results in debilitating pain. By Tuesday the pain, immobility, and strengthless-ness had spread gradually to my left pectoral muscle, my left rear deltoids, my left elbow, my left forearm and slightly into my left pinky and ring fingers. Wednesday (today) all the symptoms from Tuesday are still present with the added symptom that maintaining proper posture through my left shoulder is also painful so now I'm hunching on my left side.
Information has been received from a nurse concerning a 71 year old white retired female with osteopenia, hypertension and hyperlipidaemia and no drug reactions/allergies who on 12-NOV-2007 was vaccinated with pneumococcal 23v polysaccharide vaccine (lot # 658074/0803U), 0.5mL, intramuscularly in the right deltoid. Concomitant therapy included LIPITOR, DYAZIDE, calcium (unspecified), vitamin D (unspecified) and baby aspirin. On the evening of 13-NOV-2007, the patient developed red blotches that were warm to the touch all over her shoulders and arm. On 14-NOV-2007, the patient sought medical attention. The physician recommended that the patient ice the area (s) and take ADVIL. As of 14-NOV-2007, the patient had not recovered. The product quality complaint unit was not involved. Follow up information received, stated that the patient was recovered on 19-Nov-2007. Additional information has been requested.
This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 05Apr2021 at 10:30 (at the age of 53-years-old), as a single dose for COVID-19 immunisation. Medical history included reactive airways/asthma and known allergy to sulfa drugs. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 08:00, on Friday; 4 days after the first dose, the patient was very dizzy and a little nauseous. The patient had received first dose vaccine on Monday. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events very dizzy and a little nauseous were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
1 day p/vax pt devel a rash & swelling @ inj site;2 days post vax the swelling inc & the area was hot to touch;pt also exp numbness & tingling in lt arm, pain ulnar nerve diff, & gen muscle & joint aches;tx w/meds;
Case number PHEH2012US021060 is an initial spontaneous report received from a nurse on 15 Oct 2012. This case refers to a female patient of unspecified age. She was vaccinated with FLUVIRIN (batch number: 1204901, expiration date: May 2013) on 13 Oct 2012. She immediately experienced streaking at the injection site and then later in the face and abdomen. Then she experienced shortness of breath and chest pain. She also experienced rash and nausea. She was treated at hospital emergency room with BENADRYL and prednisone. Her symptoms dissipated after treatment. She was not treated in hospital overnight. The causality was not reported. No other information was available.
1 day of vax feverish-pain @ inj site, malaise, poor appetite, fever 102.6 cultured-no other organisms isolated;